Lilly goes direct for non-PBS meds

Lilly has made a move to improve the price competitiveness of some of its non-PBS listed drugs by launching a platform to facilitate dispensing of them and delivery to a patient's home, starting with Mounjaro.

To see the whole article please log in.

James Quintana Pearce

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here